Yeang, Calvin
Cotter, Bruno
Tsimikas, Sotirios
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (NIH R01-HL119828, P01-HL088093, P01 HL055798, R01-HL106579, R01-HL078610, R01-HL124174.)
Article History
First Online: 18 January 2016
Compliance with Ethical Standards
:
: NIH R01-HL119828, P01-HL088093, P01 HL055798, R01-HL106579, R01-HL078610, R01-HL124174.
: Dr. Tsimikas is a co-inventor of and receive royalties from patents owned by the University of California San Diego on oxidation-specific antibodies. Dr. Tsimikas has a dual appointment at UCSD and as an employee at Isis Pharmaceuticals, Inc. The other authors report no conflicts.